Chemoproteomics Reveals Glaucocalyxin A Induces Mitochondria‐Dependent Apoptosis of Leukemia Cells via Covalently Binding to VDAC1
Advanced Biology · 2024
DOI: 10.1002/adbi.202300538 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, 2024. Verfasst von Yehai An und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences and School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Diterpenes, Kaurane. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, National Natural Science Foundation of China.
Abstract (Originalsprache)
Chronic myelogenous leukemia (CML) that is resistant to tyrosine kinase inhibitors is one of the deadliest hematologic malignancies, and the T315I mutation in the breakpoint cluster region‐Abelson (BCR‐ABL) kinase domain is the most prominent point mutation responsible for imatinib resistance in CML. Glaucocalyxin A (GLA), a natural bioactive product derived from the Rabdosia rubescens plant, has strong anticancer activity. In this study, the effect and molecular mechanism of GLA on imatinib‐sensitive and imatinib‐resistant CML cells harboring T315I mutation via a combined deconvolution strategy of chemoproteomics and label‐free proteomics is investigated. The data demonstrated that GLA restrains proliferation and induces mitochondria‐dependent apoptosis in both imatinib‐sensitive and resistant CML cells. GLA covalently binds to the cysteine residues of mitochondrial voltage‐dependent anion channels (VDACs), resulting in mitochondrial damage and overflow of intracellular apoptotic factors, eventually leading to apoptosis. In addition, the combination of GLA with elastin, a mitochondrial channel VDAC2/3 inhibitor, enhances mitochondria‐dependent apoptosis in imatinib‐sensitive and ‐resistant CML cells, representing a promising therapeutic approach for leukemia treatment. Taken together, the results show that GLA induces mitochondria‐dependent apoptosis via covalently targeting VDACs in CML cells. GLA may thus be a candidate compound for the treatment of leukemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences and School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
- State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
- State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
- Department of Nephrology, Shenzhen Key Laboratory of Kidney Diseases, and Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital, The First Affiliated Hospital, Southern University of Science and T…
- Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
ORCID-Profile: Piao Luo, Jigang Wang
Förderung
- National Key Research and Development Program of China
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Public Welfare Research Institutes
- Shenzhen Science and Technology Innovation Commission
- Distinguished Expert Project of Sichuan Province Tianfu Scholar
- the Shenzhen Medical Research Fund of Shenzhen Medical Academy of Research and Translation
- the Distinguished Expert Project of Sichuan Province Tianfu Scholar
Zitieren
APA
An, Y., Zhang, Q., Chen, Y., Xia, F., Wong, Y. K., He, H., Hao, M., Tian, J., Zhang, X., Luo, P., & Wang, J. (2024). Chemoproteomics Reveals Glaucocalyxin A Induces Mitochondria‐Dependent Apoptosis of Leukemia Cells via Covalently Binding to VDAC1. Advanced Biology. https://doi.org/10.1002/adbi.202300538
Vancouver
An Y, Zhang Q, Chen Y, Xia F, Wong YK, He H, et al. Chemoproteomics Reveals Glaucocalyxin A Induces Mitochondria‐Dependent Apoptosis of Leukemia Cells via Covalently Binding to VDAC1. Advanced Biology. 2024. doi:10.1002/adbi.202300538
BibTeX
@article{An2024,
author = {An, Yehai and Zhang, Qian and Chen, Yu and Xia, Fei and Wong, Yin-Kwan and He, Hengkai and Hao, Mingjing and Tian, Jiahang and Zhang, Xiaoyong and Luo, Piao and Wang, Jigang},
title = {Chemoproteomics Reveals Glaucocalyxin A Induces Mitochondria‐Dependent Apoptosis of Leukemia Cells via Covalently Binding to VDAC1},
journal = {Advanced Biology},
year = {2024},
doi = {10.1002/adbi.202300538}
}
EUVIMED